Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease

Noormohammad Noori 1 , Ghasem Miri Aliabad 1 , * and Ali Khajeh 1
Authors Information
1 Department of Pediatrics, Children and Adolescent Health Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: January 28, 2015, 17 (1); e1939
  • Published Online: June 25, 2013
  • Article Type: Case Report
  • Received: March 1, 2013
  • Accepted: May 20, 2013

To Cite: Noori N, Miri Aliabad G, Khajeh A. Retrospective, Single Center Study of Clinical, Paraclinical and Natural Course of Infantile-Onset Pompe Disease, Zahedan J Res Med Sci. 2015 ; 17(1):e1939.

Abstract
Copyright © 2015, Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
Footnotes
References
  • 1. Jones HN, Muller CW, Lin M, Banugaria SG, Case LE, Li JS, et al. Oropharyngeal dysphagia in infants and children with infantile Pompe disease. Dysphagia. 2010; 25(4): 277-83[DOI][PubMed]
  • 2. Kliegman R, Stanton B, St. Geme J. Nelson text book of pediatrics. 2011; : 499-500
  • 3. van Gijn J, Gijselhart JP. [Pompe and his disease]. Ned Tijdschr Geneeskd. 2011; 155[PubMed]
  • 4. Hirschhorn R, Reuser AJ. The Metabolic and molecular bases of inherited disease. 2001; : 3389-420
  • 5. Goldstein JL, Young SP, Changela M, Dickerson GH, Zhang H, Dai J, et al. Screening for Pompe disease using a rapid dried blood spot method: experience of a clinical diagnostic laboratory. Muscle Nerve. 2009; 40(1): 32-6[DOI][PubMed]
  • 6. Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr. 2000; 137(2): 283-5[DOI][PubMed]
  • 7. van der Ploeg AT, Reuser AJ. Pompe's disease. Lancet. 2008; 372(9646): 1342-53[DOI][PubMed]
  • 8. Kemper AR, Hwu WL, Lloyd-Puryear M, Kishnani PS. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations. Pediatrics. 2007; 120(5)-34[DOI][PubMed]
  • 9. Di Rocco M, Buzzi D, Taro M. Glycogen storage disease type II: clinical overview. Acta Myol. 2007; 26(1): 42-4[PubMed]
  • 10. Acmg Work Group on Management of Pompe Disease , Kishnani PS, Steiner RD, Bali D, Berger K, Byrne BJ, et al. Pompe disease diagnosis and management guideline. Genet Med. 2006; 8(5): 267-88[PubMed]
  • 11. Bembi B, Cerini E, Danesino C, Donati MA, Gasperini S, Morandi L, et al. Diagnosis of glycogenosis type II. Neurology. 2008; 71(23 Suppl 2)-11[DOI][PubMed]
  • 12. Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem. 2001; 47(8): 1378-83[PubMed]
  • 13. van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003; 112(2): 332-40[PubMed]
  • 14. Kishnani PS, Hwu WL, Mandel H, Nicolino M, Yong F, Corzo D, et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006; 148(5): 671-6[DOI][PubMed]
  • 15. Willemsen MA, Jira PE, Gabreels FJ, van der Ploeg AT, Smeitink JA. [Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease]. Ned Tijdschr Geneeskd. 1998; 142(24): 1388-92[PubMed]
  • 16. Marsden D. Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study. Genet Med. 2005; 7(2): 147-50[PubMed]
  • 17. Zhang HB, Zhang WM, Qiu JJ, Meng Y, Qiu ZQ. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease]. Zhonghua Er Ke Za Zhi. 2012; 50(6): 415-9[PubMed]
  • 18. Byrne BJ, Kishnani PS, Case LE, Merlini L, Muller-Felber W, Prasad S, et al. Pompe disease: design, methodology, and early findings from the Pompe Registry. Mol Genet Metab. 2011; 103(1): 1-11[DOI][PubMed]
  • 19. Levine JC, Kishnani PS, Chen YT, Herlong JR, Li JS. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. Pediatr Cardiol. 2008; 29(6): 1033-42[DOI][PubMed]
  • 20. Haskins M. Gene therapy for lysosomal storage diseases (LSDs) in large animal models. ILAR J. 2009; 50(2): 112-21[PubMed]
  • 21. Koeberl DD, Kishnani PS, Chen YT. Glycogen storage disease types I and II: treatment updates. J Inherit Metab Dis. 2007; 30(2): 159-64[DOI][PubMed]
  • 22. Sun B, Zhang H, Franco LM, Young SP, Schneider A, Bird A, et al. Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II. Mol Ther. 2005; 11(1): 57-65[DOI][PubMed]
  • 23. Pascual SI. Phenotype variations in early onset Pompe disease: diagnosis and treatment results with Myozyme. Adv Exp Med Biol. 2009; 652: 39-46[DOI][PubMed]
  • 24. Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008; 122(1)-45[DOI][PubMed]
  • 25. van der Beek NA, Hagemans ML, van der Ploeg AT, Reuser AJ, van Doorn PA. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. Acta Neurol Belg. 2006; 106(2): 82-6[PubMed]
  • 26. Leslie N, Tinkle BT. Gene Reviews™ [Internet]. 1993;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments